rabbit polyclonal antibodies against atg5 (Proteintech)
Structured Review

Rabbit Polyclonal Antibodies Against Atg5, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 576 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+antibodies+against+atg5/ATG5+Antibody/pmc12673406-69-15-36
Average 96 stars, based on 576 article reviews
Images
1) Product Images from "Pioglitazone Reduces Hepatic Alpha-1 Antitrypsin Accumulation Through Autophagy and AMPK Activation in Alpha-1 Antitrypsin Deficient Mice"
Article Title: Pioglitazone Reduces Hepatic Alpha-1 Antitrypsin Accumulation Through Autophagy and AMPK Activation in Alpha-1 Antitrypsin Deficient Mice
Journal: American journal of physiology. Gastrointestinal and liver physiology
doi: 10.1152/ajpgi.00272.2025
Figure Legend Snippet: (A) Western blot analysis of autophagy-related proteins in HuhZ cells treated with pioglitazone (10 μM, 48 h), with or without Bafilomycin A1 (BafA1, 100 μM, 6 h). Protein levels of ATG5, p62, and LC3B were assessed. GAPDH serves as a loading control. (B) Quantification of p62 and LC3B-II band intensities from (A), normalized to GAPDH. Bars represent mean ± SD from three independent experiments. (C) Immunofluorescence staining of LC3B (green) in HuhZ cells treated with pioglitazone ± BafA1. Nuclei were counterstained with DAPI (blue). Insets show enlarged views of LC3B-positive puncta. (D) Western blot analysis of AMPK-mTOR signaling components in control and pioglitazone-treated HuhZ cells. Phosphorylation of AMPK, ULK1, and mTOR was assessed. (E) Quantification of p-AMPK, p-ULK1, and p-mTOR band intensities from (D), normalized to GAPDH. Bars show mean ± SD. (F) Immunofluorescence staining of p-AMPK (green) and actin (red) in control and pioglitazone-treated HuhZ cells. Nuclei were counterstained with DAPI (blue). Merged images show increased p-AMPK activation upon pioglitazone treatment.
Techniques Used: Western Blot, Control, Immunofluorescence, Staining, Phospho-proteomics, Activation Assay
Figure Legend Snippet: (A) Western blot analysis of liver lysates from control- and pioglitazone-treated Pi*Z mice (30 mg/kg/day, 12 weeks) showing levels of total AAT, ATG5, LC3B-I/II, and p62. GAPDH is shown as a loading control. (B) Quantification of Western blot band intensities from (A), normalized to GAPDH. Data represents SD from 4 mice per group. Statistical significance assessed by unpaired t-test. (C) Immunohistochemistry for LC3B in liver sections from control and pioglitazone-treated mice. The right panel shows higher magnification with arrows indicating LC3B-positive vacuoles. (D) Immunohistochemistry for p62 in liver sections from control and pioglitazone-treated mice. p62-positive aggregates are reduced in pioglitazone-treated livers. Scale bars: 100 μm (all panels).
Techniques Used: Western Blot, Control, Immunohistochemistry
Related Articles
Incubation:Article Title: Pioglitazone Reduces Hepatic Alpha-1 Antitrypsin Accumulation Through Autophagy and AMPK Activation in Alpha-1 Antitrypsin Deficient Mice. Article Snippet: 25 Background: Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder characterized by 26 accumulation of misfolded Z α-1 antitrypsin (ZAAT) in hepatocytes, leading to liver injury 27 and metabolic dysfunction.. There is no therapy to reduce ZAAT accumulation and restore 28 proteostasis.. Pioglitazone activates AMP-activated protein kinase (AMPK), enhance 29 autophagy, and modulate ER stress responses, suggesting a potential effect on ZAAT 30 clearance. Article Title: Pioglitazone Reduces Hepatic Alpha-1 Antitrypsin Accumulation Through Autophagy and AMPK Activation in Alpha-1 Antitrypsin Deficient Mice Article Snippet: Equal amounts of protein were separated on Tris-Glycine SDS-PAGE gels (Bio-Rad, Hercules, CA) and transferred onto nitrocellulose membranes (Bio-Rad, Hercules, CA) using a wet transfer system. .. The blots were blocked in 5% non-fat dried milk and incubated overnight at 4°C with |


